Drugs for Kidney Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 907)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Nicotinamide |
Approved, Investigational |
Phase 4 |
|
98-92-0 |
936 |
Synonyms:
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
Acid amide
Amid kyseliny nikotinove
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra brand OF niacinamide
Austrovit PP
b 3, Vitamin
b3, Vitamin
Benicot
beta-Pyridinecarboxamide
b-Pyridinecarboxamide
Delonin amide
Dipegyl
Dipigyl
Endobion
Enduramide
Factor PP
FREEDERM
Hansamid
Inovitan PP
Jenapharm brand OF niacinamide
Jenapharm, nicotinsäureamid
m-(Aminocarbonyl)pyridine
Mediatric
Merck brand OF niacinamide
NAM
Nandervit-N
Niacevit
Niacin
Niacinamide
Niacinamide astra brand
Niacinamide jenapharm brand
Niacinamide merck brand
Niacinamide pharmagenix brand
Niamide
NIATIN
Niavit PP
NICAM
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
|
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamide
Nicotinamidum
Nicotinate amide
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsäureamid jenapharm
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Niocinamide
Niozymin
NSC-13128
NSC-27452
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix brand OF niacinamide
PP-Faktor
Propamine a
PYRIDINE-3-CARBOXAMIDE
Pyridine-3-carboxylic acid amide
Savacotyl
Vi-nicotyl
Vi-noctyl
Vitamin b 3
Vitamin b3
Vitamin PP
Witamina PP
Β-pyridinecarboxamide
|
|
2 |
|
Amiodarone |
Approved, Investigational |
Phase 4 |
|
1951-25-3 |
2157 |
Synonyms:
2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone
2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
Alphapharm brand OF amiodarone hydrochloride
Aminodarone
Amio-Aqueous IV
Amiobeta
Amiodarex
Amiodarona
Amiodarona [INN-Spanish]
AMIODARONE
Amiodarone base
Amiodarone HCL
Amiodarone hydrochloride
amiodarone hydrochloride|Cordarone®
Amiodarons
Amiodaronum
Amiodaronum [INN-Latin]
Amiohexal
Aratac
Armstrong brand OF amiodarone hydrochloride
Arycor
ASTA medica brand OF amiodarone hydrochloride
Berenguer infale brand OF amiodarone hydrochloride
Betapharm brand OF amiodarone hydrochloride
|
Braxan
Corbionax
Cordarex
Cordarone
Cordarone Intravenous
g Gam brand OF amiodarone hydrochloride
Hexal brand OF amiodarone hydrochloride
Hydrochloride, amiodarone
Kordaron
L-3428
Labaz
Leurquin brand OF amiodarone hydrochloride
Ortacrone
PACERONE
Pharma investi brand OF amiodarone hydrochloride
pms-Amiodarone
Rytmarone
Sanofi winthrop brand OF amiodarone hydrochloride
SKF 33134 a
SKF 33134-a
SKF-33134A
Tachydaron
Trangorex
Wyeth brand OF amiodarone hydrochloride
|
|
3 |
|
Triamterene |
Approved |
Phase 4 |
|
396-01-0 |
5546 |
Synonyms:
6-Phenyl-2,4,7-triaminopteridine
6-PHENYLPTERIDINE-2,4,7-TRIAMINE
Ademin
Ademine
Diren
Ditak
Diurene
Dyren
Dyrenium
Dyrenium®|Dytac®|SK-8542
Dytac
Goldshield brand OF triamterene
Jatropur
Jorba brand OF triamterene
Noridil
Noridyl
NSC-639359
NSC-77625
Pterofen
Pterophene
|
SK&F-8542
SK-8542
SmithKline beecham brand OF triamterene
Taturil
Teriam
Teridin
Triampur
Triamteren
Triamterena
TRIAMTERENE
TRIAMTÉRÈNE
TRIAMTERENO
Triamterenum
Triamteril
Triamteril complex
Trispan
Tri-span
Triteren
Urocaudal
Wellspring brand OF triamterene
|
|
4 |
|
Chlorhexidine |
Approved, Vet_approved, Withdrawn |
Phase 4 |
|
55-56-1 |
2713 9552079 |
Synonyms:
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
AVAGARD
CHLORHEXIDIN
CHLORHEXIDIN [CZECH]
CHLORHEXIDINE
CHLORHEXIDINUM
CHLORHEXIDINUM [INN-LATIN]
Cloresidina
CLORESIDINA [DCIT]
CLORHEXIDINA
CLORHEXIDINA [INN-SPANISH]
|
Dentisept
EXIDINE
HIBISTAT
Merfen-incolore
N-(4-CHLOROPHENYL)-1-3-(6-{N-[3-(4-CHLOROPHENYL)CARBAMIMIDAMIDOMETHANIMIDOYL]AMINO}HEXYL)CARBAMIMIDAMIDOMETHANIMIDAMIDE
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NOLVASAN
PERIDEX
STERILON
SUTHOL
SUTHOOOL
|
|
5 |
|
Capsaicin |
Approved |
Phase 4 |
|
404-86-4 |
1548943 |
Synonyms:
(e)8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide(8CL)
8 Methyl N vanillyl 6 nonenamide
8-Methyl-N-vanillyl-6-nonenamide
Alacan brand OF capsaicin
ALGRX 4975
ALGRX-4975
Antiphlogistine rub a-535 capsaicin
Axsain
CAPSAICIN
Capsaicina
Capsaicine
Capsicum farmaya
Capsidol
Capsin
Capzasin
Carter horner brand OF capsaicin
Centrum brand OF capsaicin
e-Capsaicin
Elan brand OF capsaicin
epsilon-Capsaicin
FEMA NO. 3404
Flemming brand OF capsaicin
|
Gelcen
Isodecenoate
Isodecenoate vanillylamide
Isodecenoic acid
Isodecenoic acid vanillylamide
Katrum
Link brand OF capsaicin
Medicis brand OF capsaicin
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
NGX-1998
NGX-4010
NSC-56353
QUTENZA
Qutenza®
Smaller brand OF capsaicin
Styptysat
Thompson brand OF capsaicin
trans-8-Methyl-N-vanillyl-6-nonenamide
Transacin
Vinas brand OF capsaicin
Zacin
Zostrix
ZOSTRIX HP
|
|
6 |
|
Leflunomide |
Approved, Investigational |
Phase 4 |
|
75706-12-6 |
3899 |
Synonyms:
5-Methylisoxazole-4-carboxylate (4-trifluoromethyl)anilide
5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide
a,a,a-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
ARABLOC
Arabloc®|Arava®|HWA 486|HWA-486|lefunamide|SU-101
Arava
Aventis behring brand OF leflunomide
Aventis brand OF leflunomide
Aventis pharma brand OF leflunomide
Hoechst brand OF leflunomide
HWA 486
HWA-486
|
L04AA13
Leflunomida
LEFLUNOMIDE
Léflunomide
Leflunomidum
Leflunomidum [INN-Latin]
LEFUNAMIDE
LEFUNOMIDE
Lefunomide [INN-Spanish]
N-(4-Trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide
SU101
SU-101
SULOL
Α,α,α-trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
|
|
7 |
|
Digoxin |
Approved |
Phase 4 |
|
20830-75-5 |
3062 2724385 30322 |
Synonyms:
[<sup>3</sup>H]-digoxin
12beta-Hydroxydigitoxin
12b-Hydroxydigitoxin
12Β-hydroxydigitoxin
AWD.pharma brand OF digoxin
Bertek brand OF digoxin
Boehringer, digoxina
Cardoxin
Cogoxin
Cordioxil
Davoxin
DGO621
Digacin
DIGAMEX
DIGAZOLAN
Digitalis glycoside
Digitek
Digitekt
Digoregen
Digossina
Digoxin
Digoxin pediatric
Digoxina
Digoxina boehringer
Digoxine
Digoxine nativelle
Digoxinum
Dilanacin
Dixina
Dokim
Dynamos
Eudigox
Glaxo wellcome brand OF digoxin
GlaxoSmithKline brand 1 OF digoxin
GlaxoSmithKline brand 2 OF digoxin
|
Hemigoxine nativelle
Homolle'S digitalin
Kern brand OF digoxin
Lanacordin
Lanacrist
LANADICOR
Lanicor
Lanoxicaps
Lanoxin
LANOXIN PEDIATRIC
Lanoxin PG
Lanoxin®
LANOXIN-125
Lanoxin-PG
Lenoxicaps
Lenoxin
Lilly brand OF digoxin
Longdigox
Mapluxin
Nativelle, digoxine
Nativelle, hemigoxine
Neodioxanin
Neo-lanicor
Novartis brand OF digoxin
NSC-95100
Proctor and gamble brand OF digoxin
R.A.N. brand OF digoxin
Roche brand OF digoxin
Rougoxin
SK-Digoxin
Stillacor
Teofarma brand OF digoxin
UDL brand OF digoxin
Vanoxin
Virco brand OF digoxin
|
|
8 |
|
Peginterferon alfa-2b |
Approved |
Phase 4 |
|
215647-85-1, 99210-65-8 |
|
Synonyms:
Interferon alfa-2b
Intron A
Peginterferon alfa-2b
PEGINTRON
|
PEG-INTRON
PegIntron®|Sylatron®
rIFN-alpha-2b
Unitron PEG
|
|
9 |
|
Moxonidine |
Approved, Investigational |
Phase 4 |
|
75438-57-2 |
4810 |
Synonyms:
(2R,4R)-1-[(2S)-5-[(AMINOIMINOMETHYL)AMINO]-1-OXO-2-[[(1,2,3,4-TETRAHYDRO-3-METHYL-8- QUINOLINYL)SULFONYL]AMINO]PENTYL]-4-METHYL-2-PIPERIDINECARBOXYLIC ACID
4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine
BDF5896
BDF-5896
BE5895
BE-5895
Cynt
FISIOTENS
Lilly brand OF moxonidine
LY326869
LY-326869
|
Moxon
Moxonidin
Moxonidina
MOXONIDINE
Moxonidinum
NORCYNT
Normatens
NUCYNT
Physiotens
Solvay brand OF moxonidine
Zint
|
|
10 |
|
Acarbose |
Approved, Investigational |
Phase 4 |
|
56180-94-0 |
441184 444254 |
Synonyms:
Acarbosa
Acarbose
Acarbosum
Bay g 5421
Bayer brand OF acarbose
BAY-G 5421
BAY-G 5421|BAY-G-5421|Glucobay®|Precose®
|
BAY-G-5421
Glucobay
Glucor
Glumida
Lasa brand OF acarbose
Prandase
Precose
|
|
11 |
|
Vildagliptin |
Approved, Investigational |
Phase 4 |
|
274901-16-5 |
6918537 |
Synonyms:
(2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
EQUA
Galvus
Galvus®|LAF-237|NVP-LAF237
Jalra
LAF 237
LAF237
LAF-237
|
NVP LAF237
NVP-LAF 237
NVP-LAF237
NVP-LAF-237
Vildagliptin
Vildagliptina
Xiliarx
|
|
12 |
|
Darbepoetin alfa |
Approved, Investigational |
Phase 4 |
|
209810-58-2 |
|
Synonyms:
ARANESP
ARANESP SURECLICK
Darbepoetin
DARBEPOETIN ALFA
Darbepoetin alfa,recombinant
Darbepoetina alfa
|
EPOETIN
ERYTHROPOIETIN PRECURSOR
KRN321
KRN-321
NESP
|
|
13 |
|
Captopril |
Approved |
Phase 4 |
|
62571-86-2 |
44093 |
Synonyms:
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylate
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylate
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
Acediur
Aceplus
Acepress
ACEPRIL
Alopresin
Apopril
C09AA01
Capoten
Capoten®|SQ-14225
Captolane
CAPTOMEX
CAPTOPRIL
Captoprilum
Captoprilum [INN-Latin]
Captopryl
Captoril
Cesplon
|
CP
D-2-Methyl-3-mercaptopropanoyl-L-proline
D-3-Mercapto-2-methylpropanoyl-L-proline
Dilabar
ECOPACE
Garranil
Hipertil
Hypertil
HYTENEZE 12.5
HYTENEZE 25
HYTENEZE 50
KAPLON
L-Captopril
Lopirin
LOPRIL
NOYADA
SA-333
SQ -14225
SQ-14225
Tenosbon
Tensobon
Tensoprel
|
|
14 |
|
Cinacalcet |
Approved |
Phase 4 |
|
226256-56-0 |
156419 |
Synonyms:
(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
(R)-a-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
(R)-Α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
073, AMG
1493, KRN
alpha-Methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphar)-hydrochloride
AMG 073
AMG-073
AMG-073|Mimpara®|Sensipar®
|
CINACALCET
Cinacalcet hydrochloride
CNC
Hydrochloride, cinacalcet
KRN1493
KRN-1493
Mimpara
N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine
Sensipar
|
|
15 |
|
Metformin |
Approved |
Phase 4 |
|
1115-70-4, 657-24-9 |
4091 |
Synonyms:
[<sup>14</sup>C]-metformin
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
1-CARBAMIMIDAMIDO-N,N-DIMETHYLMETHANIMIDAMIDE
Apo-Metformin
BOLAMYN SR
Diabefagos
Diabex
Diaformin
DIAGEMET XL
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMBG
Fortamet
Gen-Metformin
GLUCAMET 500
GLUCAMET 850
GLUCIENT SR
Glucophage
GLUCOPHAGE SR
GLUCOPHAGE XR
Glumetza
Glycon
GLYFORMIN
HCL, Metformin
Hydrochloride, metformin
JANUMET
LA 6023
LA-6023
|
LEDERMETIN
Meguan
METABET SR
Metformin
Metformin HCL
Metformin hydrochloride
Metformina
Metformine
Metforminum
Metiguanide
METSOL
MILFORM
Mylan-Metformin
N(1),N(1)-Dimethylbiguanide
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylguanylguanidine
N,N-Dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
Novo-Metformin
NSC-91485
Nu-Metformin
Obimet
ORABET
PMS-Metformin
Ran-Metformin
Ratio-Metformin
Riomet
Sandoz Metformin
SUKKARTO SR
Teva-Metformin
XLA399
|
|
16 |
|
Carbamide peroxide |
Approved |
Phase 4 |
|
124-43-6 |
|
Synonyms:
Carbamide peroxide
Hydrogen peroxide carbamide
Urea dioxide
|
Urea hydrogen peroxide
Urea peroxide
|
|
17 |
|
Carvedilol |
Approved, Investigational |
Phase 4 |
|
72956-09-3 |
2585 |
Synonyms:
(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol
14C-Labeled carvedilol
Artist
BM 14.190
BM-14.190
BM-14190
BM-14-190
C07AG02
CARVEDILOL
Carvédilol
Carvedilol hydrochloride
Carvedilol, (-)
Carvedilol, (-)-isomer
Carvedilol, (+)
Carvedilol, (+)-isomer
Carvedilol, (+-)-isomer
Carvedilol, (R)-isomer
Carvedilol, (S)-isomer
Carvedilol, 14C labeled
|
Carvedilol, 14C-labeled
Carvedilolum
Carvedilolum [Latin]
Coreg
COREG CR
Coreg®|DQ 2466|Eucardic®|SKF 105517
Coropres
Dilatrend
DQ 2466
DQ-2466
Eucardic
EUCARDIC 12.5
EUCARDIC 25
EUCARDIC 3.125
EUCARDIC 6.25
Kredex
Querto
SKF 105517
SKF-105517
|
|
18 |
|
Alendronic acid |
Approved |
Phase 4 |
|
121268-17-5, 66376-36-1 |
2088 |
Synonyms:
(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)
(4-Amino-1-hydroxybutylidene)bisphosphonate
(4-Amino-1-hydroxybutylidene)bisphosphonic acid
4 amino 1 Hydroxybutylidene 1,1 biphosphonate
4-amino-1-hydroxybutane-1,1-diphosphonic acid
4-Amino-1-hydroxybutylidene 1,1-biphosphonate
ABDP
ABDP|BPH 1|Fosamax®|MK-217
Acide alendronique
Acide Alendronique [INN-French]
Acido alendronico
Acido Alendronico [INN-Spanish]
Acidum alendronicum
Acidum Alendronicum [INN-Latin]
Adronat
Alendronate
|
Alendronate monosodium salt, trihydrate
Alendronate sodium
Alendronate sodium hydrate
Alendronic acid
Alendros
Aminohydroxybutane bisphosphonate
Arendal
BINOSTO
Bisphosphonate, aminohydroxybutane
BPH 1
Fosamax
Fosamax Plus D
G-704650
MK-217
Onclast
Sodium, alendronate
|
|
19 |
|
Amlodipine |
Approved |
Phase 4 |
|
88150-42-9 |
2162 |
Synonyms:
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid
Almirall brand OF amlodipine besilate
Amlocard
Amlodipine
Amlodipine Benzenesulfonate
Amlodipine besilate
Amlodipine besylate
amlodipine besylate|amlodipine maleate|Copalia® (amlodipine + valsartan)|Katerzia® (amlodipine oral suspension, 1 mg/mL)|Norvasc®|UK-4834011
Amlodipine free base
Amlodipine maleate
Amlodipine maleate (1:1)
Amlodipine, (+-)-isomer
Amlodipine, (+-)-isomer, maleate (1:1)
Amlodipine, (R)-isomer
Amlodipine, (S)-isomer, maleate (1:1)
Amlodipino
Amlodipino [Spanish]
Amlodipinum
|
Amlodipinum [Latin]
Amlodis
Amlor
AMVAZ
Astudal
ASTUDAL 5
CKD-330 COMPONENT AMLODIPINE
Coroval
Eczacibasi brand OF amlodipine besilate
HGP0904
HGP-0904
Istin
Lipinox
Lotrel
Mack brand OF amlodipine besilate
NORVAS
Norvasc
Pelmec
Pfizer brand OF amlodipine besilate
Racemic amlodipine
|
|
20 |
|
Ezetimibe |
Approved |
Phase 4 |
|
163222-33-1 |
150311 |
Synonyms:
(1-(4-Fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone)
ABSORCOL
Ezedoc
Ezetimib
Ezetimiba
EZETIMIBE
ézétimibe
|
Ezetimibum
Ezetrol
MK0653
SCH 58235
SCH 58235|SCH-58235|Zetia®
SCH-58235
Zetia
|
|
21 |
|
Reviparin |
Approved, Investigational |
Phase 4 |
|
9041-08-1 |
|
Synonyms:
INNOHEP
Innohep®|tinzaparin sodium
LNH1
LNH-1
LOGIPARIN
|
Reviparin sodium
TINZAPARIN
Tinzaparin sodium
Tinzaparina
|
|
22 |
|
Hydroxyurea |
Approved |
Phase 4 |
|
127-07-1 |
3657 |
Synonyms:
Biosupressin
Carbamohydroxamate
Carbamohydroxamic acid
Carbamohydroximate
Carbamohydroximic acid
Carbamohydroxyamic acid
Carbamoyl oxime
Carbamyl hydroxamate
Carbamyl hydroxamic acid
Droxia
Droxia®|Hydrea®|hydroxycarbamide|Siklos®|SQ-1089|Xromi®
Hidrix
Hidroxicarbamida
HU
Hydrea
Hydreia
Hydroxicarbamidum
Hydroxycarbamid
Hydroxycarbamide
Hydroxycarbamidum
|
Hydroxycarbamine
Hydroxyharnstoff
Hydroxylurea
HYDROXYUREA
Hydura
Hydurea
Idrossicarbamide
Idrossicarbamide [Dcit]
Litaler
Litalir
N-Carbamoylhydroxylamine
N-HYDROXYUREA
NSC-32065
Oncocarbide
Onco-Carbide
Oxyurea
SIKLOS
SQ-1089
Sterile Urea
Ureaphil
|
|
23 |
|
Hydralazine |
Approved |
Phase 4 |
|
86-54-4 |
3637 |
Synonyms:
(1Z)-1(2H)-Phthalazinone hydrazone
(2H)-Phthalazinone hydrazone
1-Hydrazinophthalazine
1-Phthalazinylhydrazine
6-Hydralazine
APR968
Apresoline
Apressin
Apressoline
Hidral
Hidralazina
Hydralazin
HYDRALAZINE
Hydralazine hydrochloride
|
Hydralazine mono hydrochloride
Hydralazine mono-hydrochloride
Hydralazinum
Hydrallazin
Hydrallazine
Hydrazinophthalazine
Hydrazone 1(2H)-phthalazinone
Hydrochloride, hydralazine
Hypophthalin
Idralazina
mono-Hydrochloride, hydralazine
Nepresol
NSC-126699
Phthalazin-1-ylhydrazine
|
|
24 |
|
Rilonacept |
Approved, Investigational |
Phase 4 |
|
501081-76-1 |
|
Synonyms:
ARCALYST
IL-1 TRAP
IL-1-TRAP
|
interleukin-1 (IL-1) trap
INTERLEUKIN-1 TRAP
Rilonacept
|
|
25 |
|
Candesartan cilexetil |
Approved |
Phase 4 |
|
145040-37-5 |
|
Synonyms:
1-(Cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid
1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
Amias
Atacand
Blopress
CANDESARTAN
|
Candesartan cilexetil
Kenzen
Parapres
RATACAND
TCV 116
TCV-116
|
|
26 |
|
Telavancin |
Approved |
Phase 4 |
|
372151-71-8 |
21014972 3081362 |
Synonyms:
5,15-Dichloro-48-({3-[(4-{[2-(decylamino)ethyl]amino}-5-hydroxy-4,6-dimethyloxan-2-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl}oxy)-2,18,20,23,26,32,35,37,42,44-decahydroxy-19-{[1-hydroxy-4-methyl-2-(methylamino)pentylidene]amino}-22-[(C-hydroxycarbonimidoyl)methyl]-36-{[(phosphonomethyl)amino]methyl}-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2,.2,.1,.1,.0,.0,]pentaconta-3,5,8,10,12(48),14,16,20,23,26,29(45),30,32,34,36,38,41,43,46,49-icosaene-40-carboxylate
N(3'')-[2-(DECYLAMINO)ETHYL]-29-{[(PHOSPHONOMETHYL)AMINO]METHYL}VANCOMYCIN
TD-6424
Telavancin
|
Telavancina
Télavancine
Telavancinum
|
|
27 |
|
Lercanidipine |
Approved, Investigational |
Phase 4 |
|
100427-26-7 |
65866 |
Synonyms:
Biohorm brand OF lercanidipine hydrochloride
Lercadip
LERCANIDIPINE
Lercanidipine hydrochloride
Lercanidipino
|
Lercanil
Lerdip
Methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Zanidip
|
|
28 |
|
Clonidine |
Approved |
Phase 4 |
|
4205-91-8, 4205-90-7 |
2803 20179 |
Synonyms:
2-((2,6-Dichlorophenyl)imino)imidazolidine
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2-[(2,6-Dichlorophenyl)imino]imidazoline
Adesipress
Boehringer ingelheim brand OF clonidine hydrochloride
Catapres
CATAPRES P.L.
CATAPRES TTS 1
CATAPRES TTS 2
CATAPRES TTS 3
Catapres®|Kapvay®
Catapresan
Catapressan
Catapres-TTS
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
Catarpres
Catarpresan
Catarpres-TTS
Chlofazoline
Chlophazolin
Chlornidinum
Clofelin
Clofenil
Clonidin
Clonidina
Clonidine
Clonidine dihydrochloride
CLONIDINE HCL
Clonidine hydrochloride
|
Clonidine monohydrobromide
Clonidine monohydrochloride
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
CLORPRES
COMBIPRES
DICHLORANILINO IMIDAZOLIN
Dihydrochloride, clonidine
Dixarit
DURACLON
Duraclont
Gemiton
Hemiton
Hydrochloride, clonidine
Ipotensium
Isoglaucon
JENLOGA
KAPVAY
KAPVAY®
Klofelin
Klofenil
Monohydrobromide, clonidine
Monohydrochloride, clonidine
ST 155BS
ST-155
ST-155BS
ST-155-BS
Tenso-Timelets
|
|
29 |
|
Olmesartan |
Approved, Investigational |
Phase 4 |
|
144689-63-4, 144689-24-7 |
158781 130881 |
Synonyms:
(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid
(5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
4-(Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346
866, CS
Benicar
Benicar HCT
Benicar®|CS-866|Olmetec®
|
CS-866
DE-092
HCT, Benicar
Medoxomil, olmesartan
OLMESARTAN
Olmesartan medoximil
Olmesartan medoxomil
Olmesartan medoxomil tablets
Olmetec
Omesartan
RNH-6270
Votum
|
|
30 |
|
Ribavirin |
Approved |
Phase 4 |
|
36791-04-5 |
37542 |
Synonyms:
1-b-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-b-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-Β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
1-Β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
Copegus
Copegus®|RBV|Rebetol®|ribofluranosyl carboxamide|Virazole®
Dermatech brand OF ribavirin
Essex brand OF ribavirin
Grossman brand OF ribavirin
ICN brand OF ribavirin
Merck brand OF ribavirin
NSC-163039
Pfizer brand OF ribavirin
RBV
Rebetol
Rebetron
Rebretron
Ribamide
Ribamidil
Ribamidyl
RIBAPAK
Ribasphere
RIBAV
RIBAVARIN
Ribavirin
|
Ribavirin Capsules
Ribavirin merck brand
Ribavirin Triphosphate
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirin-TP
Ribavirinum
Ribavirinum [INN-Latin]
RIBOFLURANOSYL CARBOXAMIDE
Ribovirin
RTC
RTCA
RTP
SCH 18908
SCH-18908
Three rivers pharmaceuticals brand OF ribavirin
Tribavirin
Varazid
Vilona
VIRAMID
Viramide
VIRAZID
Virazide
Virazole
Virazole 5'-triphosphate
|
|
31 |
|
Aminophylline |
Approved |
Phase 4 |
|
317-34-0 |
9433 |
Synonyms:
Aminofilina
AMINOPHILLINE
AMINOPHYLLIN
AMINOPHYLLINE
AMINOPHYLLINE DYE FREE
AMINOPHYLLINE IN SODIUM CHLORIDE
Aminophyllinum
AMMOPHYLLIN
AMNIVENT-225 SR
AMNIVENT-350 SR
|
NSC-7919
PETERPHYLLIN
PHYLLOCONTIN
SOMOPHYLLIN
SOMOPHYLLIN-DF
Theophyline ethylenediamine
THEOPHYLLAMINE
THEOPHYLLINE ETHYLENEDIAMINE
TRUPHYLLINE
|
|
32 |
|
Regadenoson |
Approved, Investigational |
Phase 4 |
|
313348-27-5 |
22451303 219024 |
Synonyms:
1-{6-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboximidate
CVT-3146
CVT-3146|Lexiscan®|Rapiscan®
|
Lexiscan
REGADENOSON
Regadenoson anhydrous
|
|
33 |
|
Cilostazol |
Approved, Investigational |
Phase 4 |
|
73963-72-1 |
2754 |
Synonyms:
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
CILOSTAZOL
Cilostazole
Cilostazolum
|
Cilostazolum [INN-Latin]
OPC-13013
OPC-13013|OPC-21|Pletal®
OPC-21
Pletaal
Pletal
|
|
34 |
|
Lamivudine |
Approved, Investigational |
Phase 4 |
|
134678-17-4 |
60825 |
Synonyms:
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
(-)-2'-Deoxy-3'-thiacytidine
2',3' Dideoxy 3' thiacytidine
2',3'-Dideoxy-3'-thiacytidine
3TC
3'-Thia-2',3'-dideoxycytidine
BCH 189
BCH 189, (-)-
BCH-189
beta-L-2',3'-Dideoxy-3'-thiacytidine
beta-L-3'-Thia-2',3'-dideoxycytidine
b-L-2',3'-Dideoxy-3'-thiacytidine
b-L-3'-Thia-2',3'-dideoxycytidine
Epivir
|
EPIVIR-HBV
Epzicom
GR-109714X
Hepitec
HEPTOVIR
LAMIVUDIN
LAMIVUDINA
LAMIVUDINE
Lamivudine [Usan:Ban:Inn]
Lamivudine, (2S-cis)-isomer
LAMIVUDINUM
ZEFFIX
Β-L-2',3'-dideoxy-3'-thiacytidine
Β-L-3'-thia-2',3'-dideoxycytidine
|
|
35 |
|
Pitavastatin |
Approved |
Phase 4 |
|
147511-69-1 |
5282452 |
Synonyms:
(e,3R,5S)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid
Itavastatin
Itavastatin calcium
itavastatin|Livalo®
Livalo
Nisvastatin
NK 104
NK-104
|
NKS104
Pitavastatia
PITAVASTATIN
Pitavastatin calcium
Pitavastatin lactone
Pitavastatina
Pitavastatine
Pitavastatinum
|
|
36 |
|
Insulin glulisine |
Approved |
Phase 4 |
|
207748-29-6 |
|
Synonyms:
APIDRA
APIDRA SOLOSTAR
HMR1964
HMR-1964
INS APIDRA
INS APIDRA OPTICLIK
|
INS APIDRA OPTISET
INS APIDRA SOLOSTAR
INSULIN GLULISINE
Insulin Glulisine (recombinant DNA origin)
INSULIN GLULISINE RECOMBINANT
Insulina glulisina
|
|
37 |
|
Dexmedetomidine |
Approved, Experimental, Vet_approved |
Phase 4 |
|
86347-14-0, 113775-47-6 |
68602 5311068 |
Synonyms:
(+)-4-((S)-a,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-Α,2,3-trimethylbenzyl)imidazole
(+-)-4-(a,2,3-Trimethylbenzyl)imidazole
(+-)-4-(alpha,2,3-Trimethylbenzyl)imidazole
(+-)-4-(Α,2,3-trimethylbenzyl)imidazole
(+)-MEDETOMIDINE
(±)-4-(α,2,3-trimethylbenzyl)imidazole
(S)-MEDETOMIDINE
Dexdor
Dexdor®|Igalmi® (dexmedetomidine sublingual film)|MPV 1440|Precedex®
DEXMEDETOMIDIN
Dexmedetomidina
DEXMEDETOMIDINE
DEXMÉDÉTOMIDINE
Dexmedetomidine hydrochloride
Dexmedetomidinum
|
Domitor
Hospira brand OF dexmedetomidine hydrochloride
Hydrochloride, dexmedetomidine
Hydrochloride, medetomidine
Levomedetomidine
Medetomidina
Medetomidina [Spanish]
Medetomidine
Medetomidine hydrochloride
Medetomidinum
Medetomidinum [Latin]
MPV 1440
MPV 785
MPV-1440
MPV-785
Precedex
|
|
38 |
|
Atenolol |
Approved |
Phase 4 |
|
29122-68-7 |
2249 |
Synonyms:
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
Aircrit
Alinor
Altol
Anselol
Antipressan
Apo-atenolol
Atcardil
Atecard
Atehexal
ATENAMIN
Atenblock
Atendol
Atenet
Ateni
Atenil
ATENIX-100
ATENIX-25
ATENIX-50
Atenol
Atenol 1a pharma
Atenol acis
Atenol al
Atenol atid
Atenol cophar
Atenol CT
Atenol fecofar
Atenol gador
Atenol genericon
Atenol GNR
Atenol heumann
Atenol MSD
Atenol NM pharma
Atenol nordic
Atenol PB
Atenol quesada
Atenol stada
Atenol tika
Atenol trom
Atenol von CT
Atenolin
Atenol-mepha
Atenolol
ATENOLOL (JAN/USP)
ATENOLOL [USAN:BAN:INN:JAN]
Atenololum
ATENOLOLUM [INN-LATIN]
Atenol-ratiopharm
Atenol-wolff
Atenomel
Atereal
Aterol
Betablok
Betacard
Betasyn
Betatop ge
Blocotenol
Blokium
C07AB03
Cardaxen
|
Cardiopress
Corotenol
Cuxanorm
Duraatenolol
Duratenol
ESATENOLOL
Evitocor
Farnormin
Felo-bits
Hipres
Hypoten
Ibinolo
ICI 66082
ICI-66082
Internolol
Jenatenol
Juvental
KENTOL
Loten
Lo-ten
Lotenal
Myocord
Myocord®|Normiten®|Tenormin®
Normalol
Normiten
Noten
Oraday
Ormidol
Panapres
Plenacor
Premorine
Prenolol
Prenormine
Prinorm
Scheinpharm atenol
Seles beta
Selobloc
Serten
Servitenol
Stermin
Tenidon
Teno-Basan
Tenobloc
Tenoblock
Tenolol
Tenoprin
Tenoretic
Tenormin
TENORMIN 25
TENORMIN L.S.
Tenormine
TENORMINE [FRENCH]
Tensimin
TOTAMOL
Tredol
Unibloc
Uniloc
VASATEN
Vascoten
Vericordin
Wesipin
Xaten
|
|
39 |
|
Doxazosin |
Approved |
Phase 4 |
|
74191-85-8 |
3157 |
Synonyms:
1 (4-amino-6,7-Dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine
1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin
Alfamedin
Aliud brand OF doxazosin mesylate
Almirall brand OF doxazosin mesylate
Alpharma brand OF doxazosin mesylate
Alter brand OF doxazosin mesylate
apo Doxazosin
apo-Doxazosin
Apogepha brand OF doxazosin mesylate
Apotex brand OF doxazosin mesylate
AstraZeneca brand OF doxazosin mesylate
Azupharma brand OF doxazosin mesylate
Betapharm brand OF doxazosin mesylate
C02CA04
Cantabria brand OF doxazosin mesylate
Cardular
Cardura
Cardura XL
Cardura®|UK-3327427
Carduran
Carduran neo
Ciclum brand OF doxazosin mesylate
Cinfa brand OF doxazosin mesylate
combino Brand OF doxazosin mesylate
CT Arzneimittel brand OF doxazosin mesylate
CT, Doxazosin von
CT-Arzneimittel brand OF doxazosin mesylate
Diblocin
Doxa puren
Doxacor
Doxagamma
Doxamax
Doxa-puren
Doxatensa
DoxaUro
Doxazomerck
Doxazosin
Doxazosin al
Doxazosin apogepha
Doxazosin azu
Doxazosin beta
Doxazosin findusfit
Doxazosin heumann
Doxazosin klast
Doxazosin mesilate
Doxazosin mesylate
Doxazosin monohydrochloride
Doxazosin ratiopharm
Doxazosin stada
Doxazosin von CT
Doxazosin wolff
Doxazosina
|
Doxazosina alter
Doxazosina cinfa
Doxazosina combino pharm
Doxazosina geminis
Doxazosina normon
Doxazosina pharmagenus
Doxazosina ratiopharm
Doxazosina ur
Doxazosine
Doxazosin-ratiopharm
Doxazosinum
Doxazosin-wolff
Esparma brand OF doxazosin mesylate
FindusFit brand OF doxazosin mesylate
Geminis brand OF doxazosin mesylate
Gen doxazosin
Gen-doxazosin
Genpharm brand OF doxazosin mesylate
Heumann brand OF doxazosin mesylate
Hexal brand OF doxazosin mesylate
Juta brand OF doxazosin mesylate
Jutalar
Kade brand OF doxazosin mesylate
Linden brand OF doxazosin mesylate
Merck dura brand OF doxazosin mesylate
Mesylate, doxazosin
Monohydrochloride, doxazosin
MTW Brand OF doxazosin mesylate
MTW Doxazosin
MTW-Doxazosin
neo, Carduran
Normon brand OF doxazosin mesylate
novo Doxazosin
novo-Doxazosin
Novopharm brand OF doxazosin mesylate
Pfizer brand OF doxazosin mesylate
Pharmagenus brand OF doxazosin mesylate
Progandol neo
Q Pharm brand OF doxazosin mesylate
Q-Pharm brand OF doxazosin mesylate
ratio Doxazosin
ratio-Doxazosin
Ratiopharm brand OF doxazosin mesylate
Ratiopharm, doxazosina
Solvay brand OF doxazosin mesylate
Stadapharm brand OF doxazosin
TAD brand OF doxazosin mesylate
UK-33274
UK-3327427
Uriduct
Von CT, doxazosin
Wolff brand OF doxazosin mesylate
Wörwag brand OF doxazosin mesylate
Zoxan
|
|
40 |
|
Quinapril |
Approved, Investigational |
Phase 4 |
|
82586-55-8, 85441-61-8 |
54892 |
Synonyms:
(3S)-2-{N-[(2S)-1-ethoxycarbonyl-4-phenylbutan-2-yl]-L-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylate
(3S)-2-{N-[(2S)-1-ethoxycarbonyl-4-phenylbutan-2-yl]-L-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
2-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid
Accupril
Accuprin
ACCUPRO
Acequin
Acuitel
C09AA06
CI 906
|
CI-906
Korec
Quinapril
QUINAPRIL HCL
Quinapril hydrochloride
Quinaprilum
Quinaprilum [Latin]
Quinazil
QUINIL
|
|
41 |
|
Manidipine |
Approved, Investigational |
Phase 4 |
|
89226-50-6 |
4008 |
Synonyms:
2-(4-Diphenylmethyl-1-piperazinyl)ethyl methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
3-{2-[4-(diphenylmethyl)piperazin-1-yl]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid
Artedil
MANIDIPINE
Manidipine 6300
|
Manidipine dihydrochloride
MANIDIPINE HCL
Manidipine hydrochloride
Manidipine, (+-)-isomer
Manidipino
|
|
42 |
|
Alemtuzumab |
Approved, Investigational |
Phase 4 |
|
216503-57-0 |
|
Synonyms:
ALEMTUZUMAB
ALEMTUZUMAB (GENETICAL RECOMBINATION)
CAMPATH
campath 1H|Campath®|campath-1H|Lemtrada®
CAMPATH MABCAMPATH
CAMPATH MABCAMPATH, LEMTRADA
|
CAMPATH-1H
GZ402673
GZ-402673
LDP-03
LEMTRADA
MABCAMPATH
|
|
43 |
|
Verapamil |
Approved |
Phase 4 |
|
152-11-4, 52-53-9 |
2520 |
Synonyms:
Akilen
Anpec
ANSYR
Ansyr®|CP-165331 / CP-16533-1|Securon®
Apo-verap
Arpamyl
Arpamyl LP
BERKATENS
CALAN
CALAN SR
Calaptin
Calaptin 240 SR
Calcan
Cardiabeltin
Cardiagutt
Cardibeltin
Cardioprotect
Caveril
Civicor
Civicor retard
Coraver
CORDILOX
CORDILOX I.V.
CORDILOX MR 240
Cordilox SR
Corpamil
COVERA
COVERA-HS
CP-165331
CP-16533-1
CP-165331 / CP-16533-1
CP-16533-1Calan
CP-165331Verapamil
D-365
D-365Iproveratril
delta-365
Dexverapamil
Dignover
Dilacoran
Dilacoran hta
Drosteakard
Durasoptin
Elthon
ETHIMIL MR 240
Falicard
Finoptin
Flamon
GEANGIN
HALF SECURON SR
Harteze
Hexasoptin
Hexasoptin retard
Hormitol
Hydrochloride, verapamil
Ikacor
Ikapress
Inselon
Iproveratril
Isoptimo
ISOPTIN
Isoptin retard
ISOPTIN SR
Isoptine
Isoptino
Isotopin
Izoptin
Jenapamil
Lekoptin
Lodixal
LU-20175
Magotiron
Manidon
Manidon retard
MANIDON SR
Novapamyl LP
Novo-veramil
|
NSC-272306NA
NSC-272366
NSC-657799
Nu-verap
Ormil
Praecicor
Quasar
RANVERA MR
Rapam
Robatelan
Sandoz brand OF verapamil
SECURON
SECURON IV
SECURON MID
SECURON SR
Tarka
UNIVER
Univex
Vasolan
Vasomil
Vasopten
Verabeta
Veracaps SR
Veracim
Veracor
Verahexal
Veraloc
Veramex
Veramil
Verapamil
Vérapamil
Verapamil [Usan:Ban:Inn]
Verapamil acis
Verapamil al
Verapamil atid
Verapamil basics
Verapamil ebewe
VERAPAMIL HCL
Verapamil henning
Verapamil hydrochloride
Verapamil injection
Verapamil MSD
Verapamil NM
Verapamil NM pharma
Verapamil nordic
Verapamil PB
Verapamil riker
Verapamil sandoz brand
Verapamil SR
Verapamil verla
Verapamil-abz
Verapamilo
Verapamilo [INN-Spanish]
Verapamilum
Verapamilum [INN-Latin]
Verapin
Verapress 240 SR
VERAPRESS MR 240
Veraptin
Verasal
Vera-sanorania
Verasifar
Veratensin
VERA-TIL SR
Verdilac
VERELAN
VERELAN PM
Verelan SR
Verexamil
Veroptinstada
Verpamil
VERTAB SR 240
Vetrimil
Vortac
ZOLVERA
|
|
44 |
|
Nystatin |
Approved, Vet_approved |
Phase 4 |
|
1400-61-9 |
11953884 |
Synonyms:
ABBR nyt
BARSTATIN 100
CANDEX
INFESTAT
KOROSTATIN
MULTILIND
MYCO 20
Mycostatin
MYKINAC
NILSTAT
Nistatina
NSC-150817
|
NYS
NYSERT
NYSPES
NYSTAFORM
NYSTAN TRIPLE PACK
Nystatin
Nystatine
Nystatinum
NYSTAVESCENT
NYSTEX
NYSTOP
TINADERM M
|
|
45 |
|
Rocuronium |
Approved |
Phase 4 |
|
119302-91-9, 143558-00-3 |
441290 |
Synonyms:
1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
Esmeron
Esmerone
ORG-9426
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
|
Rocuronio
ROCURONIUM
Rocuronium bromide
Zemuron
|
|
46 |
|
Pamidronic acid |
Approved |
Phase 4 |
|
40391-99-9 |
4674 |
Synonyms:
(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate
(3-Amino-1-hydroxypropylidene)-1,1-bisphosphonate
1 Hydroxy 3 aminopropane 1,1 diphosphonic acid
1-Hydroxy-3-aminopropane-1,1-diphosphonic acid
ACIDE PAMIDRONIQUE
Acide pamidronique [INN-French]
ACIDO PAMIDRONICO
Acido pamidronico [INN-Spanish]
ACIDUM PAMIDRONICUM
Acidum pamidronicum [INN-Latin]
AHPrBP
Amidronate
Amino 1 hydroxypropane 1,1 diphosphonate
Amino-1-hydroxypropane-1,1-diphosphonate
Aminohydroxypropylidene diphosphonate
|
Aminomux
Aminopropanehydroxydiphosphonate
APD
ARD233
Aredia
Aredia®|CGP-23339AE|disodium pamidronate
CGP-23339AE
Novartis brand OF pamidronate disodium salt
PAMIDRONATE
Pamidronate calcium
Pamidronate disodium
Pamidronate monosodium
Pamidronic acid
Ribodroat
|
|
47 |
|
Zoledronic acid |
Approved |
Phase 4 |
|
118072-93-8 |
68740 |
Synonyms:
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonate
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonate
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
ácido zoledrónico
ACLASTA
Aclasta®|CGP-42446|CGP-42446A|Reclast®|zoledronate|Zometa®
ANHYDROUS ZOLEDRONIC ACID
CGP-42446
CGP-42446A
Novartis brand OF zoledronic acid
|
Reclast
ZERLINDA
ZOL
ZOL446
ZOLEDRONATE
Zoledronic acid
Zoledronic acid anhydrous
ZOLEDRONIC ACID HYDRATE
ZOLEDRONIC ACID MONOHYDRATE
ZOLEDRONIC ACID, ANHYDROUS
Zometa
Zometa Concentrate
|
|
48 |
|
Alprostadil |
Approved, Investigational |
Phase 4 |
|
745-65-3 |
5280723 |
Synonyms:
(-)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
(-)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
(-)-Prostaglandin e1
(+)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
(+)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
(11Α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-Oate
(11Α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-Oic acid
(13E)-(15S)-11,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11-alpha,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11-alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid (acd/name 4.0)
11a,15a-Dihydroxy-9-oxo-13-trans-prostenoate
11a,15a-Dihydroxy-9-oxo-13-trans-prostenoic acid
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoate
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid
11Α,15α-dihydroxy-9-oxo-13-trans-prostenoate
11Α,15α-dihydroxy-9-oxo-13-trans-prostenoic acid
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
7-[(1R,2R,3R)-3-HYDROXY-2-[(1E,3S)-3-HYDROXYOCT-1-EN-1-YL]-5-OXOCYCLOPENTYL]HEPTANOIC ACID
Abbott brand OF alprostadil
Allphar brand OF alprostadil
Alprostadil
ALPROSTADIL ALFADEX
Alprostadil prostoglandin e1
Alprostadil®|MR-256|prostaglandin E<sub>1</sub>
Alprostadil(usan)
Alprostadilum
Astra brand OF alprostadil
AstraZeneca brand OF alprostadil
Befar
|
Caverject
Caverject impulse
Edex
Hoyer brand OF alprostadil
Janssen brand OF alprostadil
lipo PGE1
lipo-PGE1
L-Prostaglandin e1
Minprog
MR-256
Muse
NSC-165559
ONO-1608
Paladin brand OF alprostadil
PGE1
PGE-1
PGE₁
PGE1 Α-CD
PGE1alpha
Pharmacia brand 1 OF alprostadil
Pharmacia brand 2 OF alprostadil
Prink
PRINK (TN)
Prostaglandin e1
Prostaglandin e1alpha
Prostavasin
PROSTIN
Prostin VR
Prostin VR pediatric
Prostine VR
Schwarz brand OF alprostadil
Schwarz pharma brand OF alprostadil
Sugiran
U-10136
U-10136alprostadil
U-10136prostin
Vasaprostan
Viridal
VIRIDAL 10
VIRIDAL 20
VIRIDAL 5
VIRIDAL DUO
Vitaros
Vivus brand OF alprostadil
|
|
49 |
|
Vancomycin |
Approved |
Phase 4 |
|
1404-90-6 |
14969 |
Synonyms:
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(2.2SP,3.5SA,2.6SP)-O(4.2),C(3.4)
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-b-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-b-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-β-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-β-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
Abbott brand OF vancomycin hydrochloride
AB-vancomycin
Azupharma brand OF vancomycin hydrochloride
C(5.4),O(4.6)
Cell pharm brand OF vancomycin hydrochloride
Chiesi brand OF vancomycin hydrochloride
Combino brand OF vancomycin hydrochloride
Curasan brand OF vancomycin hydrochloride
Dakota brand OF vancomycin hydrochloride
Diatracin
Dista brand OF vancomycin hydrochloride
Eli lilly brand OF vancomycin hydrochloride
Hexal brand OF vancomycin hydrochloride
Hydrochloride, vancomycin
Lilly brand OF vancomycin hydrochloride
MIP brand OF vancomycin hydrochloride
Norman brand OF vancomycin hydrochloride
Ratiopharm brand OF vancomycin hydrochloride
|
Sulfate, vancomycin
Vanco azupharma
Vanco-cell
Vancocin
Vancocin HCL
Vancocine
VANCOLED
Vancomicin
Vancomicina
Vancomicina abbott
Vancomicina chiesi
Vancomicina combino phar
Vancomicina norman
VANCOMYCIN
Vancomycin HCL
Vancomycin hexal
Vancomycin hydrochloride
Vancomycin lilly
Vancomycin phosphate (1:2)
Vancomycin phosphate (1:2), decahydrate
Vancomycin sulfate
Vancomycine
Vancomycine dakota
Vancomycin-ratiopharm
Vancomycinum
VANCOR
Vanco-saar
|
|
50 |
|
Asunaprevir |
Approved, Investigational, Withdrawn |
Phase 4 |
|
630420-16-5 |
23595629 |
Synonyms:
|
Interventional clinical trials:
(show top 50)
(show all 5642)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis:A Multicenter Randomized Controlled Clinical Trial |
Unknown status |
NCT04349683 |
Phase 4 |
Jinshuibao;Placebo |
2 |
Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2 |
Unknown status |
NCT01561222 |
Phase 4 |
Calcitriol;placebo |
3 |
Effect of Sodium Glucose co Transporter 2 (SGLT2) Inhibition on Optical Coherence Tomography Angiography (OCT-A) Parameters in Diabetic Chronic Kidney Disease (CKD) |
Unknown status |
NCT04215445 |
Phase 4 |
Empagliflozin 25 MG |
4 |
Effects of Cholecalciferol on Osteoprotegerin Levels and Other Clinical Outcomes in Chronic Kidney Disease Patients on Peritoneal Dialysis: a Randomized Controlled Trial |
Unknown status |
NCT02598635 |
Phase 4 |
Cholecalciferol;Placebo |
5 |
Mechanisms of Low Protein Diet Supplemented With α-ketoacids on Autophagy and Improving Muscle Wasting in Chronic Kidney Disease: the Role of Autophagy in Muscle Wasting |
Unknown status |
NCT02568020 |
Phase 4 |
keto-amino acids |
6 |
The Immunogenicity and Safety of the Seasonal Influenza Vaccine, Formulation 2013-2014, in Chronic Kidney Disease Patients Not on Dialysis |
Unknown status |
NCT02105519 |
Phase 4 |
|
7 |
Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure |
Unknown status |
NCT00716001 |
Phase 4 |
N-acetylcysteine |
8 |
Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease |
Unknown status |
NCT02299310 |
Phase 4 |
Valsartan;Perindopril |
9 |
Comparison of Efficacy and Safety Between Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension: a Randomized Controlled Trial |
Unknown status |
NCT02646397 |
Phase 4 |
Fosinopril;Benidipine;Hydrochlorothiazide |
10 |
COmparison of the Pharmacodynamics and Pharmacokinetics of Ticagrelor Versus Clopidogrel in Patients With Chronic Kidney Disease and Non-ST-Elevation Acute Coronary Syndromes(OPT-CKD Trial) |
Unknown status |
NCT02578537 |
Phase 4 |
Ticagrelor;Clopidogrel |
11 |
Gut-kidney Axis: Renal Effects of Meditarranean Diet and Low-protein Diet With Ketoacids to Restore Physiological Intestinal Mibrobiota in Chronic Kidney Disease |
Unknown status |
NCT02302287 |
Phase 4 |
|
12 |
Effect of Aliskiren on Muscle Sympathetic Nerve Activity (MSNA) in Hypertensive Patients With Chronic Kidney Disease |
Unknown status |
NCT00719316 |
Phase 4 |
Aliskiren |
13 |
Research of Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa Produced by Immunobiological Technology Institute (Bio-Manguinhos) From Oswaldo Cruz Foundation (Bio-Manguinhos / Fiocruz) |
Unknown status |
NCT02648126 |
Phase 4 |
|
14 |
Lipid-lowering Regimes Improve Oxidative Stress, Tryptophan Degradation in Hypercholesterolemia Chronic Kidney Disease Patients |
Unknown status |
NCT03543774 |
Phase 4 |
Simvastatin 40mg;Ezetimibe/simvastatin 10/20 mg/day;Ezetimibe/simvastatin 10/40 mg/day |
15 |
A Crossover Pilot Study of the Effect of Amiloride on Proteinuria in Patients With Proteinuric Kidney Disease |
Unknown status |
NCT02522650 |
Phase 4 |
Amiloride;Triamterene |
16 |
A comParison on Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Study Among SeVerE Chronic Kidney Disease/ End-Stage-Renal-Disease Patients With Recent Acute Coronary Syndrome. |
Unknown status |
NCT02459288 |
Phase 4 |
Clopidogrel first;Ticagrelor first |
17 |
Pragmatic Randomized Controlled Trial Comparing Treatment Effectiveness of Guideline Indicated Anti-platelet Therapy for Acute Coronary Syndrome in Patients With Chronic Kidney Disease |
Unknown status |
NCT03150667 |
Phase 4 |
Ticagrelor;Clopidogrel |
18 |
Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney Disease |
Unknown status |
NCT03596957 |
Phase 4 |
Tolvaptan |
19 |
Influence of Vitamin K2 Administration on Vessel Calcification Markers in Patients With Chronic Kidney Disease |
Unknown status |
NCT01101698 |
Phase 4 |
Vitamin K2+10μg cholecalciferol;Vitamin D |
20 |
Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease |
Unknown status |
NCT02364648 |
Phase 4 |
|
21 |
Effect of Renin-angiotensin-system (RAS) Blocker Drugs on Chronic Kidney Disease (CKD) Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01) |
Unknown status |
NCT03195023 |
Phase 4 |
Lisinopril;Amlodipine |
22 |
Clinical Trial Simulation Using ODE/PDE Hemodialysis Model for Quantifying Oxycodone's Removal in End-Stage Kidney Disease |
Unknown status |
NCT02452437 |
Phase 4 |
Oxycodone |
23 |
Comparison of the Effects Between Keto-/Amino Acid Supplemented Low Protein Diet and Non-Supplemented Low Protein Diet in Patients With Stage Ⅴ Chronic Kidney Disease |
Unknown status |
NCT00364884 |
Phase 4 |
ketoaminoacid |
24 |
Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease |
Unknown status |
NCT00204256 |
Phase 4 |
Iron sucrose |
25 |
Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease: An Interventional and Methodological Study |
Unknown status |
NCT00235287 |
Phase 4 |
Candesartan and enalapril;candesartan and enalapril |
26 |
Randomized, Open, Multicenter Study to Evaluate the Renal Function of HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria |
Unknown status |
NCT03550859 |
Phase 4 |
Telmisartan/Rosuvastatin 40/10mg;Telmisartan 40mg |
27 |
A Randomised Open Label, Blinded End Point Trial to Compare the Effects of Spironolactone With Chlortalidone on LV Mass in Stage 3 Chronic Kidney Disease (SPIRO-CKD) |
Unknown status |
NCT02502981 |
Phase 4 |
Spironolactone;Chlortalidone |
28 |
Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease |
Unknown status |
NCT02885857 |
Phase 4 |
Shenyan Kangfu Tablet |
29 |
The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease |
Unknown status |
NCT01157260 |
Phase 4 |
Kremezin |
30 |
Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease: a Randomized Clinical Trial |
Unknown status |
NCT01155128 |
Phase 4 |
|
31 |
Renoprotection by Combining Pentoxifylline and Angiotensin Blockade in Chronic Kidney Disease |
Unknown status |
NCT01377285 |
Phase 4 |
ARB;Pentoxifylline;Placebo (for Pentoxifylline) |
32 |
Additive Renoprotective Effects of Oral Calcitriol in Nondiabetic Chronic Kidney Disease Patients |
Unknown status |
NCT01512862 |
Phase 4 |
Calcitriol;Placebo |
33 |
Efficacy and Safety of Morning Intake of Simvast Controlled Release (CR) Tablet Versus Evening Intake of Zocor Tablet in Chronic Kidney Disease Stage(CKD)3, 4 and 5 Patients With Hyperlipidemia: A Randomized, Double-blind, Multicenter Phase 4 Trial (HM-SIM4) |
Unknown status |
NCT01564875 |
Phase 4 |
Simvast CR;Zocor |
34 |
Intradialytic Exercise for Enhanced Dialysis Adequacy and Solute Removal in Chronic Kidney Disease Patients: A Randomised Controlled Trial. |
Unknown status |
NCT01481688 |
Phase 4 |
|
35 |
Phase IV Study for Efficacy and Safety of Evolocumab Added to Ezetimibe (Standard of Care) in High Cardiovascular Risk Haemodialized Statin Intolerant Patients With Hypercholesterolemia |
Unknown status |
NCT04659525 |
Phase 4 |
Evolocumab;Ezetimibe;Placebo |
36 |
A Prospective Randomized, Double-Blind Parallel Group Trial To Assess The Efficacy And Safety Of Intravenous Dextrose 5% Solution Compare With Normal Saline (Standard Care) In Rinsing During Haemodialysis In Subjects With End Stage Renal Failure (ESRF) With Respect To Systolic Blood Pressure Control Over 3 Months Period. |
Unknown status |
NCT02590081 |
Phase 4 |
Dextrose 5%;normal saline |
37 |
The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Chronic Kidney Diseases Patients With Persistent Proteinuria |
Unknown status |
NCT00858299 |
Phase 4 |
valsartan |
38 |
Pentoxifylline Effect on Renal Function, Oxidative Stress, Inflammation, and Fibrosis Markers, and Quality of Life in Patients With Diabetic Nephropathy |
Unknown status |
NCT03664414 |
Phase 4 |
pentoxifylline |
39 |
Phase IV Study for Efficacy and Safety of Evolocumab Added to Ezetimibe (Standard of Care) in High Cardiovascular Risk Haemodialized Statin Intolerant Patients With Hypercholesterolemia |
Unknown status |
NCT04397653 |
Phase 4 |
Evolocumab;Placebo;Ezetimibe |
40 |
Preventing Contrast Induced Nephropathy After Transcatheter Aortic Valve Replacement |
Unknown status |
NCT03121053 |
Phase 4 |
sodium bicarbonate;hypotone saline |
41 |
Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis |
Unknown status |
NCT02338635 |
Phase 4 |
Ursodeoxycholic Acid |
42 |
A Randomized Prospective Trial of N-acetyl Cystein in Patients With Peritoneal Dialysis |
Unknown status |
NCT01111422 |
Phase 4 |
N-acetylcysteine |
43 |
Phase 4 Study of Medical Therapy Versus Medical Therapy Plus Renal Artery Stenting in Preventing the Progression of Renal Failure in Atherosclerotic Renovascular Disease |
Unknown status |
NCT01023373 |
Phase 4 |
Medical treatment |
44 |
Phase 4 Study of Sarpogrelate That Prevent Contrast-induced Nephropathy |
Unknown status |
NCT01165567 |
Phase 4 |
sarpogrelate |
45 |
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease:a Multicentre Open Study |
Unknown status |
NCT02231138 |
Phase 4 |
Abelmoschus manihot (AM) |
46 |
Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients: Single-centre, Prospective, Observational Study |
Unknown status |
NCT03470961 |
Phase 4 |
Anti-Tlymphocyte Globulins;Anti-Thymocyte Globulins |
47 |
Phase 4 Study of Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD |
Unknown status |
NCT01820832 |
Phase 4 |
Calcitriol |
48 |
The Role of Qutenza (Topical Capsaicin 8%) in Treating Neuropathic Pain From Critical Ischaemia in Patients With End-stage Renal Failure |
Unknown status |
NCT01704339 |
Phase 4 |
QUTENZA |
49 |
Evaluation of Nail Fold Microcirculation and Interventional Therapy in Patients With Chronic Renal Failure |
Unknown status |
NCT03682952 |
Phase 4 |
Alprostadil Injection;Beraprost sodium tablets |
50 |
Simvastatin Effect on Endothelium Dependent Venodilation in Chronic Renal Failure Patients Treated by Peritoneal Dialysis |
Unknown status |
NCT00291863 |
Phase 4 |
Simvastatin |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Albumin Human, USP
ALBUMIN,HUMAN INJ
|
Dopamine
Dopamine Hydrochloride
|
Cochrane evidence based reviews: kidney diseases
|